https://www.selleckchem.com/pr....oducts/acetylcystein
05). Furthermore, tumors expressing USP22 were associated with poorer patient prognosis than the USP22-negative tumors. The multivariate Cox regression analysis suggested that the level of USP22 protein is a predictive factor for survival (p less then 0.05). CONCLUSIONS Our results indicate a significant association between USP22 level and poor prognosis in NB. Thus, USP22 represents a valuable biomarker for predicting the outcome of patients with NB.The hypothalamic-pituitary-adrenal (HPA) axis has been of interest in attempts t